Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Exploring the Benefits of Independent Private Practice in Optometry

As optometry continues to evolve, an increasing number of practitioners are considering independent private practice as a career path. This change is driven by a desire for the freedom to specialize and to make autonomous decisions about patient care and business operations. However, along with the benefits comes a unique set of…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from CooperVision on MarketScale.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

As optometry continues to evolve, an increasing number of practitioners are considering independent private practice as a career path. This change is driven by a desire for the freedom to specialize and to make autonomous decisions about patient care and business operations. However, along with the benefits comes a unique set of challenges, including mastering essential business management skills.

The question is: how does one navigate this territory successfully?

This is the central query in the newest episode of ECP Viewpoints from CooperVision, featuring Dr. Mike Shaheen from Hills and Dales Vision Care. He brings his personal experience of independent private practice to light. Dr. Shaheen’s experience highlights the value of family angles in his environment. He and his family have the freedom to specialize ins sports vision or glaucoma treatment.

In the episode, Dr. Shaheen touches upon the following critical points:

  1. The liberty associated with practicing in an independent environment, including opportunities to specialize.
  2. The significant role of the family in shaping his journey toward optometry.
  3. The importance of business management skills when owning a practice.

Dr. Shaheen says, “Being in an independent practice gives you freedom – optometrists can practice how they want and delve into different areas of interest.”

Inspired by his uncle, an optometrist for 50 years, Dr. Shaheen exemplifies a successful optometry career within the independent private practice setting. His insights offer valuable lessons for those considering this pathway, emphasizing the balance between freedom, control, and business management challenges.

CooperVision

Part of this channel

CooperVision

News, updates, and expert insights from CooperVision.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

CMS Sets $90-$420 Per-Patient Payments for Chronic Care Tech

CMS Sets $90-$420 Per-Patient Payments for Chronic Care Tech

CMS's ACCESS payment model, fully active as of July 2026, pays companies $90 to $420 per Medicare beneficiary per year for technology-supported chronic care tied to outcomes, according to HFMA. The model also requires participants to connect through CMS-designated interoperability networks, and more tech companies than traditional providers have signed on so far.

  • 01CMS ACCESS model provides annual payments of $90 to $420 per Medicare beneficiary for chronic care supported by technology.
  • 02Payments in the ACCESS model range from $90 to $420 per beneficiary per year depending on whether specified outcome targets are met.
  • 03The initiative aims to promote the integration of technology in chronic care management.

Sep 10, 2026

Google’s AlphaGenome Atlas puts billions of DNA variants in reach

Google’s AlphaGenome Atlas puts billions of DNA variants in reach

AlphaGenome Atlas gives researchers predicted molecular effects for possible DNA changes across the human genome, helping teams prioritize variants for experimental follow-up.

  • 01The Atlas covers roughly nine billion possible single-letter DNA substitutions, according to The Verge.
  • 02Predictions can prioritize research questions but do not establish clinical findings.
  • 03The useful implementation pattern is prediction, study-specific evidence, then validation.

Sep 9, 2026

OpenAI put 10,000 AI agents on Navier–Stokes. Healthcare R&D should pay attention

OpenAI put 10,000 AI agents on Navier–Stokes. Healthcare R&D should pay attention

OpenAI says roughly 10,000 AI agents produced a proposed Navier–Stokes solution in 88 hours, followed by Lean verification. For healthcare and life sciences, the immediate signal is a research workflow built around parallel agents, code execution, provenance and formal checking—not a ready-made clinical simulator.

  • 01OpenAI's result is a proposed proof under review, not a new clinical simulation product.
  • 02The near-term B2B signal is a coordinated research stack combining agents, code and formal verification.
  • 03Healthcare buyers should evaluate provenance, reproducibility, security and cost per validated result.

Sep 9, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512